Massachusetts · Ranked 648 of 1033 by CEO pay.
Dana-Farber Cancer Institute
Benjamin Ebert MD PhD, Trustee, President, & CEO (As Of 10/1/24). Fiscal year ending 2025-09.
Form 990 Part VII, columns D+E+F
Schedule H Part I line 7a
The chief executive's title on the filing indicates a change during the year (TRUSTEE, PRESIDENT, & CEO (AS OF 10/1/24)); the pay shown is what the filing reports for that person, which may cover part of the year.
Also listed with a chief executive title in the same filings: Laurie H Glimcher MD, President & CEO Emerita, $2,679,650. Where a chief executive retired during the year, the filing reports the final-year payout.
§1The filing
- Total revenue
- $3,917,771,259
- Total expenses
- $3,825,086,627
- Net assets
- $4,483,632,272
- Employees
- 9,731
- Hospitals covered
- 1 facilities across 1 filing
- Charity care, net
- $14,237,969
- Bad debt
- $1,646,424
- Medicare surplus (shortfall), as filed
- ($85,990,129)
- CEO pay from the organization (Part VII col. D)
- $468,091
- From related organizations (col. E)
- $0
- Other compensation, including deferred pay and nontaxable benefits (col. F)
- $63,424
- CEO total compensation (D+E+F)
- $531,515 to Benjamin Ebert MD PhD
Medicare surplus (shortfall) is Schedule H Part III line 7: Medicare revenue minus the cost of Medicare care. A figure in parentheses is a shortfall. Like bad debt, it is not community benefit on the IRS form.
Source: Form 990, Dana-Farber Cancer Institute, EIN 04-2263040, fiscal year ending 2025-09, as published by the IRS. CEO identification: ceo title.
§2Community benefit versus charity care
The rest of line 7k is Medicaid shortfall, medical education, research, subsidized services and contributions. Bad debt ($1.6M) and Medicare shortfall are reported separately by the IRS and are not community benefit on the form.
Every number on this page was copied from the filing linked above. If a figure is wrong, send the filing that contradicts it and the correction runs at the top of this page.
